Analysis of megakaryocyte growth and development factor (thrombopoietin) effects on blast cell and megakaryocyte growth in myelodysplasia.

[1]  D. Le Tessier,et al.  Fluorescence in situ hybridization on methylcellulose cultured hematopoietic stem cells from myelodysplastic syndromes. , 1998, Cancer genetics and cytogenetics.

[2]  H. Drexler,et al.  Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. , 1996, Leukemia.

[3]  H. Miyazaki,et al.  Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. , 1996, Blood.

[4]  M. Yamaguchi,et al.  Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells , 1996 .

[5]  P. Greenberg.  Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes. , 1996, Seminars in hematology.

[6]  H. Drexler,et al.  Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. , 1996, Leukemia.

[7]  Y. Matsuzawa,et al.  Coexpression of thrombopoietin and c-mpl genes in human acute myeloblastic leukemia cells. , 1996, Leukemia.

[8]  V. Broudy,et al.  Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. , 1995, The Journal of clinical investigation.

[9]  I. Matsumura,et al.  Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. , 1995, Blood.

[10]  C. Preudhomme,et al.  Prognostic value of c-mpl expression in myelodysplastic syndromes. , 1995, Leukemia.

[11]  V. Broudy,et al.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  W. Vainchenker,et al.  The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. , 1995, Blood.

[13]  M. Yamaguchi,et al.  Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells. , 1995, Blood.

[14]  R. Schreiber,et al.  In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. , 1994, Blood.

[15]  William Vainchenker,et al.  c-Mpl ligand is a humoral regulator of megakaryocytopoiesis , 1994, Nature.

[16]  Scott R. Presnell,et al.  Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo , 1994, Nature.

[17]  D. Goeddel,et al.  Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.

[18]  V. Broudy,et al.  Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome. , 1994, Leukemia.

[19]  V. Ribrag,et al.  Expression of the c-mpl proto-oncogene in human hematologic malignancies. , 1993, Blood.

[20]  W. van Putten,et al.  Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. , 1993, The New England journal of medicine.

[21]  T. Yamada,et al.  Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes. , 1993, Acta haematologica.

[22]  B. Löwenberg,et al.  Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. , 1992, Blood.

[23]  B. Brenner,et al.  In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. , 1990, Leukemia.

[24]  P. Greenberg,et al.  Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF. , 1990, Blood.

[25]  H. Zwierzina,et al.  Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects , 1989, British journal of haematology.

[26]  S. Knuutila,et al.  Colony formation by megakaryocyte progenitors in myelodysplatic syndromes , 1989, European journal of haematology.

[27]  H. Heimpel,et al.  Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. , 1989, Blood.

[28]  Koeffler Hp.  Myelodysplastic syndromes (preleukemia). , 1986 .

[29]  S. Knuutila,et al.  Megakaryocyte colony formation by bone marrow progenitors in myelodysplasia syndromes , 1986, British journal of haematology.

[30]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[31]  G. Spitzer,et al.  In vitro agar culture patterns in preleukemia and their clinical significance. , 1979, Leukemia research.